People who are taking Topamax medicine to prevent seizure attacks should thoroughly follow label instructions and doctor’s advice to achieve best results.
• Patients are advised to swallow Topamax tablet as a whole.
• If using powder form, Topamax can be mixed with soft foods like applesauce placed on a spoon, and patients should swallow the mixture immediately.
• A patient may take Topamax even if his or her stomach is empty.
• Only take Topamax as prescribed by a physician; patients are prevented from adjusting their Topamax dosage.
Unfortunately, pregnant women and those who are planning to get pregnant who are using Topamax medication are at high risk of bearing a child with birth defects such as cleft palate or hypospadias. If you or a loved one has experienced this, the legal team of Williams Kherkher may help you win remunerations to recover your loss. Find out how we may work for you today by calling (800) 220-9341.
Japanese firm Daiichi Sankyo will settle a total of $39 million in the U.S. after a whistleblower revealed that they bribed medical practitioners to have their medicines prescribed, PMLive reported on January 14.
Reports said Kathy Fragoules, a former sales representative of Daiichi Sankyo, claimed that doctors in the US were bribed through honoraria to market medicines that treat high blood pressure, including Benicar. The federal Department of Justice alleged that Daiichi Sankyo paid representatives to urge doctors to prescribe the medicines they made. US Attorney Carmen Ortiz stated that drug companies are prevented from urging doctors to prescribe their medicines through the use of luxurious entertainment and a paid speaker program. Company commercial president in the US Ken Keller stated that they are pleased to settle the civil lawsuit and will do their best to improve the company.
Sadly, high blood patients treated with Benicar are at risk of developing serious health problems that affect the digestive system. However, if you believe that you have been injured by the defective drug, the pharmaceutical lawyers of Williams Kherkher may help you win remunerations to recover your loss. Find out how we may work for you today by calling (800) 220-9341.
A two-year study conducted by researchers at the University of California in Los Angeles has discovered ways to fight signature genetic changes in melanoma tumors that causes resistance to standard drug treatments, according to patch.com.
Researchers are hopeful that now that the resistant cells can be identified, future treatments can be developed. According to Dr. Roger Lo of UCLA’s Jonsson Comprehensive Cancer Center, melanoma cells have the capability of resisting cancer-fighting BRAF and MEK inhibitors, causing a resistance to develop. He goes on to say that scientists need to now look “beyond the BRAF+MEK combination, by possibly finding a third drug, or alter how [they] prescribe the combo of drugs.”
In the United States, around 70,000 cases of melanoma are recorded annually; 8,000 of the people afflicted with the ailment are expected to die of it.
We at the Williams Kherkher Law Group promise to do our best to help people who have become victims of defective pharmaceutical products that have been known to cause adverse effects to its users, such as Viagra, which may increase the likelihood of developing melanoma, a kind of fatal skin cancer. Call our offices at (800) 220-9341 today to see if you qualify.
Last night, at around 6 p.m., a gas leak at a Southcross Energy Natural Gas Plant just north of Corpus Christi caused an explosion and subsequent fire that burned for several hours. Pipelines bringing gas into the plant were shut off, allowing the fire to eventually burn out.
Plant officials do not yet know what caused the leak, nor how much of the plant was damaged in the explosion and ensuing fire. Thankfully, no deaths or injuries were reported in connection to the incident. We will continue to monitor the situation and will post updates once more information becomes available.
The Fifth Circuit Court, a federal appeals court in New Orleans, denied London-based oil giant BP Plc’s request to review U.S. District Judge Carl Barbier’s 2014 ruling that BP and Andarko Petroleum Corp. were responsible for paying fines under the Clean Water Act after the Deepwater Horizon drilling rig exploded in 2010, the Times-Picayune reported on January 12.
The appeal was struck down in a 7-6 vote. Barbier now has the duty to assess how much BP owes in total pollution fines. This determination is bound to be finalized during the third phase of the civil trial over the Gulf of Mexico oil spill starting January 20.
Barbier made an earlier decision in September 2014 that BP had been “grossly negligent” and deemed it responsible for one of the largest oil spills the country has ever experienced, tagging the company with around $18 billion in fines.
BP asked the court to set the cap for its fines at $3,000 per barrel of oil spilled in pre-trial filings.
If you are a worker, a resident, or a businessman whose life and livelihood has been affected by the Gulf of Mexico oil spill, trust our attorneys at Williams Kherkher to help you fight for your interests and rights by filing an oil spill claim. Call us today at (800) 220-9341.
One of the recent goals that the Research Center for Advanced Materials (Climav) in Monterrey, Mexico plans to accomplish is the creation of biomedical implants to promote the domestic manufacture of said materials to avoid dependence on foreign materials and products, according to an article on Phys.org.
Climav scholar Ana Maria Arizmendi Morquecho defined biocompatibility as the ability of a certain type of material to make contact with living tissues without creating an adverse effect on the body, a characteristic important for biomedical implants.
Morquecho said the institute is currently working on a graduate-level thesis with groups of researchers to create these products. She noted that, as of the moment, they are validating in vitro and in vivo material at the laboratory level.
Research of this kind is critical, as many hip implants have resulted in serious health complications in U.S. citizens, especially DePuy hip implants. The attorneys of Williams Kherkher is dedicated to holding companies fully accountable for defective medical products and may be able to help you. Call our offices at (800) 220-9341 today to begin taking action.
The 2014 annual data report on the state of kidney disease in the United States by the United States Renal Data System, which is housed at the University of Michigan in collaboration with Arbor Research for Collaborative Health, showed that there have been fewer cases of chronic kidney disease patients reaching end-stage renal disease and succumbing to mortal conditions brought about by their illness.
This means that chronic kidney patients are living longer thanks to dialysis treatments or kidney transplants, even as the 2014 report showed an increase in people acquiring kidney disease.
The rise in kidney disease – a condition in which the kidneys lose their ability to flush out waste fluids from the body – in the United States has been attributed to an aging and overweight population.
Current statistics show that there are 636,906 individuals in the U.S. who are receiving treatments for end-stage renal disease via dialysis or kidney transplant.
Our attorneys at Williams Kherkher have successfully litigated many cases concerned with the adverse effects caused by the kidney dialysate GranuFlo. If you have experienced health complications that you believe resulted from GranuFlo, contact us today by dialing (800) 220-9341.
Qsymia and Belviq are two drugs recently approved by the U.S. Food and Drug Administration (FDA) to manage weight. They work by inducing changes in certain neurotransmitters, providing the sensation of fullness while suppressing the craving to eat.
However, clinical trials have suggested that these two drugs may have a negative effect on a person’s capacity to be attentive. Consult with your doctor immediately if you are taking one of these weight management pills and have noticed that you are experiencing any of these symptoms:
- Decreased mental alertness
- Difficulty achieving sleep and arousal balance, or the ability to get a good night sleep and wake up feeling refreshed
- Decreased mental effort, or the ability to start, continue, and finish a task
- Inconsistent performance and behavior
If taking Qsymia or Belviq has caused you harm in any way, discuss your situation with an attorney at Williams Kherkher to learn whether it qualifies you for a claim. Call us (800) 220-9341 to get a free initial assessment of your case today.
A power morcellator is a device used to remove fibroids from the uterus by breaking them up into smaller pieces and vacuuming them out of the body through a small abdominal incision. However, the U.S. Food and Drug Administration (FDA) recently released a warning about the possible spreading of unsuspected malignant tissues in the uterus during the procedure, which may result in uterine cancer.
Aside from power morcellator use, other risk factors associated with uterine cancer are:
- Early start of menstruation, or late menopause
- Hormone therapy
- No history of pregnancy
- Older age
The unjust, unwarranted, and avoidable spread of uterine cancer caused by power morcellators can affect any woman anywhere. If you are one of those who have been affected by this device, it is important to advocate for your rights. Consult with an attorney at Williams Kherkher by calling (800) 220-9341 today and learn more about how to fight for justice and compensation when hurt by this device.
A study recently published in the Journal of Clinical Oncology suggests that for ovarian cancer patients who are currently in remission, the possibility of a disease-free survival dramatically improves over time, Medscape reported on January 7.
Lead author Brenda Diegaarde of the University of Pittsburgh Cancer Institute said the prognosis for ovarian cancer improves as the patient remains disease-free overtime. The study revealed patients at the time of remission had a 48% chance of surviving for three more years without recurrence. This rate increased up to 98% for patients who survived disease-free 5 years after remission.
Some cases of ovarian cancer have been found to be associated with the use of talcum powder products. If you suspect that your ovarian cancer has resulted from talcum powder use, speak with an attorney at Williams Kherkher, who may be able to help you pursue a claim against the product’s negligent manufacturer. Call us at (800) 220-9341 for a free case assessment today.